SCHEMBL435540

SCHEMBL435540

C/C(=C\CCC(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
SLC15A2 Q16348 1/20 0.42
PPARG P37231 2/20 0.41
FNTA P49354 2/20 0.41
FNTB P49356 2/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ATM Q13315 1/20 0.40
FFAR1 O14842 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP19A1 P11511 1/20 0.40
RXRA P19793 1/20 0.40
OXER1 Q8TDS5 1/20 0.40
BACE1 P56817 1/20 0.40
CD81 P60033 1/20 0.40
EGLN1 Q9GZT9 3/20 0.38
ALKBH5 Q6P6C2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
FFAR3 O14843 1/20 0.38
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33626 1.00 LMNA (0.42) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL17499861 0.98 PPARG (0.41) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL17499944 0.98 PPARG (0.41) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL3959910 0.86 LMNA (0.37) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL431917 0.86 PPARG (0.44) LMNAPPARGFNTAFNTBMAPT
SCHEMBL431915 0.86 PPARG (0.44) LMNAPPARGFNTAFNTBMAPT
SCHEMBL2918368 0.85 KDM4E (0.45) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL2918372 0.85 KDM4E (0.45) LMNASLC15A2PPARGFNTAFNTB
SCHEMBL699959 0.84 PPARG (0.48) LMNAPPARGMAPTATMFFAR1
Succinic Acid SCHEMBL17363357 0.84 LMNA (0.42) LMNASLC15A2PPARGFNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3651248-B1 CURRENT COLLECTOR FOR ELECTRICAL STORAGE DEVICE, METHOD FOR MANUFACTURING SAME, AND COATING LIQUID USED FOR MANUFACTURING SAME SHOKO CO LTD (JP) 2026-04-08 EP claimed
EP-3890685-B1 COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE ENCAPSYS LLC (US) 2026-03-11 EP claimed
EP-3380596-B1 COATING SOLUTIONS, COATINGS FORMED THEREFROM, AND COATED MEDICAL DEVICES BIOINTERACTIONS LTD (GB) 2025-07-09 EP claimed
EP-3788105-B1 POLYMER-MODIFIED CEMENTITIOUS COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2023-03-29 EP claimed
EP-3214677-B1 ELECTRODE CURRENT COLLECTOR, METHOD OF MANUFACTURING THE SAME, ELECTRODE, LITHIUM ION SECONDARY BATTERY, REDOX FLOW BATTERY AND ELECTRIC DOUBLE LAYER CAPACITOR SHOWA DENKO KK (JP) 2019-08-28 EP claimed
EP-2705142-B1 SYNTHETIC COMPOSITION AND COATING FOR CELL CULTURE. CORNING INC (US) 2016-08-10 EP claimed
US-8840965-B2 Silicon-containing materials with controllable microstructure DOW CORNING CORPORATION (US) 2014-09-23 US claimed
US-20140150647-A1 Curable Silicate-Siloxane Mixed Matrix Membrane Compositions DOW CORNING CORPORATION (US) 2014-06-05 US claimed
EP-2181479-B1 NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY COMPRISING THE SAME LG CHEMICAL LTD (KR) 2014-05-07 EP claimed
EP-2658926-A1 CURABLE SILICATE-SILOXANE MIXED MATRIX MEMBRANE COMPOSITIONS Dow Corning Corporation (US) 2013-11-06 EP claimed
WO-2012092142-A1 CURABLE SILICATE-SILOXANE MIXED MATRIX MEMBRANE COMPOSITIONS DOW CORNING CORPORATION (US) 2012-07-05 WO claimed
EP-2034366-B1 Toner compositions XEROX CORP (US) 2012-05-30 EP claimed
EP-2112558-B1 Processes for producing toner compositions XEROX CORP (US) 2012-05-23 EP claimed
WO-2012051487-A1 SILICON-CONTAINING MATERIALS WITH CONTROLLABLE MICROSTRUCTURE DOW CORNING CORPORATION (US) 2012-04-19 WO claimed
EP-1998225-B1 Toner compositions and process of production XEROX CORP (US) 2011-06-01 EP claimed
US-20080299479-A1 Toner compositions XEROX CORPORATION 2008-12-04 US claimed
EP-0816393-B1 Curing agent for epoxy resins VANTICO AG (CH) 2003-11-19 EP claimed
EP-0816393-A2 Curing agent for epoxy resins Ciba SC Holding AG (CH) 1998-01-07 EP claimed
EP-0411711-B1 Attachment of compounds to polymeric particles using dication ethers and a kit containing same JOHNSON & JOHNSON CLIN DIAG (US) 1995-10-25 EP claimed
EP-0242080-B1 COPOLYMER COMPOSITIONS PARAGON OPTICAL INC (US) 1992-12-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299479-A1 Toner compositions TECR, EWSR1, QARS1 LMNA 3108/4885SLC15A2 3426/4885PPARG 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.